Search

Begin New Search Topic Drugs Publication Year within 5 Years

1. Mental Health Conditions and Substance Use: Comparing U.S. Needs and Treatment Capacity with Those in Other High-Income Countries

Author:
Melinda K. Abrams, Reginald D. Williams II, Katharine Fields, and Roosa Tikkanen
Publication Date:
05-2021
Content Type:
Special Report
Institution:
The Commonwealth Fund
Abstract:
About one-quarter of U.S. adults report having a mental health diagnosis such as anxiety or depression or experiencing emotional distress. This is one of the highest rates among 11 high-income countries. While U.S. adults are among the most willing to seek professional help for emotional distress, they are among the most likely to report access or affordability issues. Emotional distress is associated with social and economic needs in all countries. Nearly half of U.S. adults who experience emotional distress report such worries, a higher share than seen in other countries. The United States has some of the worst mental health–related outcomes, including the highest suicide rate and second-highest drug-related death rate. The U.S. has a relatively low supply of mental health workers, particularly psychologists and psychiatrists. Just one-third of U.S. primary care practices have mental health professionals on their team, compared to more than 90 percent in the Netherlands and Sweden.
Topic:
Health, Health Care Policy, Mental Health, Drugs, and Substance Abuse
Political Geography:
United States, Europe, and Global Focus

2. Enforcement of Drug Laws: Refocusing on Organized Crime Elite

Author:
Global Commission On Drug Policy
Publication Date:
05-2020
Content Type:
Special Report
Institution:
Global Commission On Drug Policy
Abstract:
In this first report of this decade, the Global Commission on Drug Policy outlines how the current international drug control regime works for the benefit of transnational organized crime. It highlights how years of repressive policies targeted at nonviolent drug offenders have resulted in mass incarceration and produced countless adverse impacts on public health, the rule of law, and social cohesion, whilst at the same time reinforcing criminal elites. The report argues that the top layers of criminal organizations must be disempowered, through policy responses and political will. It provides implementable recommendations for the replacement of the current policy of targeting non-violent drug offenders and resorting to mass incarceration. Law enforcement must focus on the most dangerous and protected actors and primary drivers of the corruption, violence, and chaos around illegal drug markets. The control of psychoactive substances in a rational and efficient way must be centered on people and their needs, and on a repressive approach against criminal elites who benefit from the illegal drug markets’ proceeds, and have access to high-level networks, financial and legal support as needed. Only responsible legal regulation of currently prohibited drugs, with careful implementation, has the potential to disrupt criminal organizations and deprive them of their most lucrative sources of income. The report contains research on the prerequisites for a successful transition towards the reform of the outdated ideology-based international drug control regime, and provides cutting-edge recommendations on how to ensure that international criminal organizations are effectively disempowered by the transition towards a legally regulated drug market under the control of governments.
Topic:
Crime, Health, War on Drugs, Drugs, Public Health, and Medicine
Political Geography:
Global Focus

3. Solutions for the “Vanishing Drug” Conundrum in Lebanon: A Change in the Subsidy System Coupled with a Digital Prescribing Platform

Author:
Nadim El Jamal, Ulfat Usta, Mona Nasrallah, Elie Al-Chaer, Ghassan Hamadeh, and Hussain Isma'eel
Publication Date:
11-2020
Content Type:
Working Paper
Institution:
Arab Reform Initiative (ARI)
Abstract:
The shortage of foreign currency caused by the multiple crises in Lebanon threatens the availability of pharmaceutical products, with patients experiencing shortages of many drugs despite an importation subsidy system for pharmaceuticals financed by the Central Bank’s foreign reserves. This paper describes Lebanon’s pharmaceutical supply chain and the Central Bank’s subsidy system and proposes recommendations to ensure the continuous availability of medication on pharmacy shelves.
Topic:
Health, Drugs, Medicine, and Pharmaceuticals
Political Geography:
Middle East and Lebanon